HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto Norgiolini Selected Research

Glucagon-Like Peptide Receptors

6/2022Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.
3/2022Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto Norgiolini Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
06/2022 - 03/2022
1Hypoglycemia (Reactive Hypoglycemia)
03/2022

Drug/Important Bio-Agent (IBA)

2semaglutideIBA
06/2022 - 03/2022
2Glucagon-Like Peptide ReceptorsIBA
06/2022 - 03/2022
1Complement System Proteins (Complement)IBA
03/2022